Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Ongoing HTAs by the Spanish Health Sciences Institute in Aragon

The Health Sciences Institute in Aragon (IACS) systematically evaluates healthcare technologies and facilitates the promotion of research, effective innovation, and decision-making in health services through knowledge management.

As of June 9, 2021, the IACS is working on the following assessments related to medical procedures or technologies:

  • Detection of complications of type 2 diabetes. Diabetic retinopathy;
  • Efficacy, effectiveness, and safety of intraoperative radiation therapy (IORT) in breast cancer;
  • Determination of preeclampsia biomarkers SFlt-1 and PlGF;
  • Treatment of congenital ventricular septal defect (VSD) by cardiac catheterization, with percutaneous insertion devices.

The details of the ongoing assessments can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).